Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Differences in Degree of Trapping of Low-Affinity UncompetitiveN-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block

G. A. R. Mealing, T. H. Lanthorn, C. L. Murray, D. L. Small and P. Morley
Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 204-210;
G. A. R. Mealing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. H. Lanthorn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. L. Murray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. L. Small
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Morley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

This study characterizes the trapping of block ofN-methyl-d-aspartic acid (NMDA)-induced currents by three structurally distinct, use-dependent NMDA receptor antagonists with similar rapid on-off rates. The antagonism of whole-cell currents in cultured rat cortical neurons by AR-R15896AR, ketamine, and memantine was examined. All three compounds produced a steady-state block after a 30-s coapplication, which was fully relieved after 50 s of NMDA exposure. The amplitudes of block caused by 50 μM AR-R15896AR, 10 μM ketamine, or 10 μM memantine were not significantly different, being 82 ± 1%, 80 ± 2%, and 81 ± 2%, respectively. All three NMDA receptor antagonists exhibited trapping of block that was not significantly increased by extending the agonist/antagonist coapplication beyond 30 s. Although the initial blocks were similar, after 120 s of washout without agonist present, there were significant differences in trapping of block between antagonists, as only 54 ± 3% of the AR-R15896AR block, 86 ± 1% of the ketamine block, and 71 ± 4% of the memantine block remained trapped. The lack of complete trapping is consistent with closed-channel egress by these compounds. Higher antagonist concentrations produced larger initial blocks, but the degree of trapping block was not significantly different from that at lower antagonist concentrations. The results demonstrate that differences in the degree of trapping exist among use-dependent NMDA receptor antagonists even when on and off rates are similar. These differences are correlated with measures of therapeutic index.

Footnotes

  • Send reprint requests to: Geoff Mealing, Institute for Biological Sciences, National Research Council of Canada, Building M54, Montreal Rd., Ottawa, Ontario, Canada, K1A 0R6. E-mail:geoff.mealing{at}nrc.ca

  • ↵1 Funding for this work was provided in part by the Astra Canadian Neuroprotection Network.

  • ↵2 Present address: Astra Arcus USA, Rochester, NY 14602.

  • Abbreviations:
    NMDA
    N-methyl-d-aspartic acid
    ADCI
    5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
    AP-5
    2-amino-5-phosphonopentanoic acid
    AR-R15896AR (formerly called ARL 15896AR or FPL 15896AR)
    (S)-α-phenyl-2-pyridineethanamine dihydrochloride
    9-AA
    9-aminoacridine
    EGTA
    ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    MEM
    Eagle’s minimal essential medium
    MK-801
    dizocilpine
    PBS
    Dulbecco’s phosphate-buffered saline
    • Received April 21, 1998.
    • Accepted July 31, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 288 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 288, Issue 1
1 Jan 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differences in Degree of Trapping of Low-Affinity UncompetitiveN-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Differences in Degree of Trapping of Low-Affinity UncompetitiveN-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block

G. A. R. Mealing, T. H. Lanthorn, C. L. Murray, D. L. Small and P. Morley
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 204-210;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Differences in Degree of Trapping of Low-Affinity UncompetitiveN-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block

G. A. R. Mealing, T. H. Lanthorn, C. L. Murray, D. L. Small and P. Morley
Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 204-210;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Response-Rate Suppression in Operant Paradigm as Predictor of Soporific Potency in Rats and Identification of Three Novel Sedative-Hypnotic Neuroactive Steroids
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics